Barclays PLC Increases Stake in Arteris, Inc. (NASDAQ:AIP)

Barclays PLC boosted its position in Arteris, Inc. (NASDAQ:AIP) by 321.1% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 39,396 shares of the company’s stock after acquiring an additional 30,041 shares during the period. Barclays PLC owned 0.10% of Arteris worth $304,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in the business. US Bancorp DE bought a new stake in shares of Arteris in the third quarter valued at approximately $34,000. Renaissance Technologies LLC raised its holdings in Arteris by 6.1% during the 2nd quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock valued at $861,000 after acquiring an additional 6,600 shares during the period. MetLife Investment Management LLC lifted its position in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares in the last quarter. The Manufacturers Life Insurance Company bought a new position in shares of Arteris in the second quarter worth $86,000. Finally, Algert Global LLC bought a new stake in shares of Arteris during the 2nd quarter valued at $115,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, Rosenblatt Securities restated a “buy” rating and issued a $15.00 target price on shares of Arteris in a research note on Wednesday, November 6th.

Insider Buying and Selling

In related news, CFO Nicholas B. Hawkins sold 19,299 shares of the stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total value of $157,093.86. Following the transaction, the chief financial officer now owns 192,414 shares of the company’s stock, valued at $1,566,249.96. This represents a 9.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO K Charles Janac sold 60,584 shares of Arteris stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $10.42, for a total value of $631,285.28. Following the sale, the chief executive officer now directly owns 10,134,541 shares of the company’s stock, valued at approximately $105,601,917.22. This trade represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 254,222 shares of company stock worth $2,537,693 over the last ninety days. 33.70% of the stock is owned by corporate insiders.

Arteris Stock Up 3.0 %

AIP opened at $12.25 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. Arteris, Inc. has a one year low of $4.83 and a one year high of $12.39. The firm has a market capitalization of $492.17 million, a P/E ratio of -12.76 and a beta of 1.25. The company has a fifty day moving average price of $8.89 and a 200-day moving average price of $8.05.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.